Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-03

Clinical Trial Update: Impact of Nrf2 Activation on Macrovascular, Microvascular & Leg Function & Walking Capacity in Peripheral Artery Disease [EARLY_Phase 1]

View source ↗

Summary

An early-phase clinical trial evaluating whether activating Nrf2 improves macrovascular and microvascular function, leg performance, and walking capacity in peo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Nebraska | Conditions: Peripheral Artery Disease, Peripheral Vascular Diseases | EARLY_Phase 1 | Status: RECRUITING